An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score

NCT07554469 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
Type 2 Diabetes Mellitus

Interventions

DRUG: Finerenone (Kerendia, BAY94-8862)

Sponsor

Bayer